ThomasHowardCartwrightMD

Oncology • Macon, GA

Hematologic Oncology

Co-Chairman US Oncology Gastrointestinal Research

Join to view full profile

Dr. Cartwright is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cartwright's full profile

Already have an account?

Office
777 Hemlock St
Macon, GA 31206
Phone+1 352-804-1294

Education & Training

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1981
Southern Illinois UniversityResidency, Internal Medicine, 1976 - 1979
Northwestern University The Feinberg School of MedicineClass of 1976

Certifications & Licensure

FL State Medical License 1981 - 2026
TN State Medical License 2024 - 2026
GA State Medical License 1979 - 2024
MD State Medical License 2022 - 2024
IL State Medical License 1977 - 1982
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma Start of enrollment: 2010 Jun 01
Completed
Phase 2
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Start of enrollment: 2011 Jan 27
Completed
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Start of enrollment: 2012 Apr 01
Active, not recruiting
Phase 3
MEK162 for Patients With RAS/RAF/MEK Activated Tumors Start of enrollment: 2013 Oct 10
Completed
Phase 2
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) Start of enrollment: 2015 Dec 28
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

14 citations
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in ...
Ian Chau, Marwan Fakih, Pilar García-Alfonso, Zdenĕk Linke, Ana Ruíz Casado
Cancers. 2020-03-11
31 citations
Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting
Thomas H. Cartwright, Monika Parisi, Janet L. Espirito, Thomas Wilson, Corey Pelletier
Drugs - Real World Outcomes. 2018-09-01
34 citations
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.
Bradley J. Monk, Philip E. Lammers, Thomas Cartwright, Ira Jacobs
Pharmaceuticals. 2017-01-28

Lectures

Post hoc safety and effectiveness analysis of aflibercept + FOLFIRI for patients with metastatic colorectal cancer (mCRC) previously treated with antiepidermal growth ...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

Physicians with Florida Cancer Affiliates Honored for Contributions to Clinical ResearchMarch 8th, 2016

Professional Memberships

American Society of Clinical Oncology - ASCO
Member